Targeting KRAS: from metabolic regulation to cancer treatment
Abstract The Kirsten rat sarcoma viral oncogene homolog (KRAS) protein plays a key pathogenic role in oncogenesis, cancer progression, and metastasis. Numerous studies have explored the role of metabolic alterations in KRAS-driven cancers, providing a scientific rationale for targeting metabolism in...
Saved in:
Main Authors: | Yanyan Shi, Huiling Zheng, Tianzhen Wang, Shengpu Zhou, Shiqing Zhao, Mo Li, Baoshan Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-024-02216-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
by: Qinglong Ma, et al.
Published: (2025-01-01) -
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
by: Satoru Miyazaki, et al.
Published: (2025-02-01) -
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
by: Kun Huang, et al.
Published: (2025-01-01) -
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01) -
Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer
by: Shengbin Zheng, et al.
Published: (2025-01-01)